New trial
Phase I Trial of CAR T Cells Targeting B7-H3 in Recurrent Glioblastoma
- Trial ID
- NCT05366179 on ClinicalTrials.gov
- Cancer type
- Glioma / Glioblastoma
- Published in
- New in Oncology - May 29, 2025
UNC Lineberger is evaluating the safety of intraventricular infusion of investigational B7-H3 directed CAR T cells in patients with recurrent or refractory glioblastoma, with dose-finding in subjects following surgical resection.
More in brain and CNS tumors
-
Trial result · Oct 15, 2026 · NCT04365374
Cesium-131 collagen “GammaTile” brachytherapy cuts surgical-bed recurrence vs post-op SRT in resected brain mets -
Trial result · Oct 15, 2026 · NCT03946527
Lanreotide (somatostatin analog) shows disease stabilization in advanced PPGL in a Phase 2 preprint -
New trial · Oct 15, 2026 · NCT07831772
REMIND feasibility study tests a single maintenance IMRT fraction after temozolomide-based treatment in glioblastoma -
New trial · Oct 15, 2026 · NCT07664176
Phase 1 nivolumab plus focused ultrasound and microbubbles tests blood-brain barrier opening in recurrent pediatric brain tumors -
New trial · Oct 15, 2026 · NCT07831369
Phase 2 VISTA combines valproic acid, irinotecan, and simvastatin for recurrent malignant glioma